Slingshot Biosciences · 3 hours ago
Regional Vice President, Strategic Accounts (New England)
Slingshot Biosciences is a fast-growing life sciences company focused on precision-engineered cell mimics. The Regional Vice President, Strategic Accounts will be responsible for developing client relationships, driving sales growth, and ensuring client engagement success.
BiotechnologyMedicalTherapeutics
Responsibilities
Identify and pursue new business opportunities across the New England territory to meet or exceed sales targets
Develop and execute regional sales strategies that align with overall company goals
Build a strong pipeline of prospective clients through networking, cold outreach, and lead generation activities
Cultivate and maintain strong relationships with key decision makers in the biotech, life sciences, diagnostics, and pharmaceutical sectors, leveraging industry knowledge and expertise to navigate complex consultative sales opportunities to drive sales initiatives
Conduct sales presentations to prospective clients, showcasing the value of Slingshot Biosciences’ solutions
Manage and grow relationships with existing clients in the New England territory to drive repeat business and ensure high levels of customer satisfaction
Act as the primary point of contact for clients, ensuring their needs are met and challenges are addressed
Identify opportunities for upselling and cross-selling additional products and services to existing clients
Develop in-depth knowledge of the New England market, industry trends, and key competitors
Maintain an understanding of customer needs, challenges, and decision-making processes within the New England territory
Collaborate with the marketing team to execute localized campaigns that target key prospects in the region
Communicate client feedback and insights to the marketing team to inform future product improvements
Accurately maintain sales pipeline data and provide regular reports on sales activities, progress, and forecasts
Track and analyze performance metrics to ensure sales goals are met and adjust strategies as necessary to optimize results
Attend regional industry events, conferences, and networking opportunities to build brand awareness and foster relationships with potential clients
Stay current on industry trends and competitor activity to position the company’s offerings effectively within the marketplace
Qualification
Required
Bachelor's degree in the life sciences, or related field; advanced degree preferred
Minimum of 5 years of experience in business development or sales within the biopharma industry
Proven history of achieving or exceeding sales targets and successfully managing client relationships
Excellent communication, negotiation, and relationship-building skills; ability to translate complex solutions into compelling value propositions
Strong network of contacts in the life sciences and biopharma industry in the New England area
Ability to work independently and collaboratively in a fast-paced, dynamic environment
Willingness to travel across the New England area to meet with clients and attend industry events as necessary, and to travel to company sites to attend trainings and other meetings
Highly motivated, independent, and able to manage a large territory and engage in account planning to optimize face-to-face selling time
Adept at documenting accounts, contacts and opportunities in CRM, as well as processing leads and forecasting
In-depth knowledge of biotech trends surrounding CGT and experience selling into key accounts
Experience structuring and closing complex sales (custom products, solutions, services) into the biopharma sector with a demonstrated track record of success (multi-year agreements)
Preferred
Knowledge of Flow cytometry usage in Cell therapy processes
Startup experience strongly recommended
Benefits
Benefits
Company
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Funding
Current Stage
Growth StageTotal Funding
$64.23MKey Investors
Anterra CapitalNorthpond Ventures
2024-04-26Series A· $15M
2023-02-06Series A· $26.23M
2021-07-22Series A· $23M
Recent News
Company data provided by crunchbase